Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2034 of 5804
-
Can texting a therapist beat weekly video sessions for depression?
Symptom relief CompletedThis partnership between Talkspace and the University of Washington (UW) ALACRITY Center will determine how effective unlimited text-based psychotherapy for depression is when compared to once-a-week psychotherapy. This study will also determine what the best treatment options ar…
Phase: NA • Sponsor: Talkspace • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Can COVID-19 and emergency surgery be safely managed together? a massive hospital study seeks answers
Knowledge-focused CompletedThe COVID-19 pandemic has posed a significant challenge to surgical practice. This study aims to investigate the structure of hospitalizations, treatment outcomes, and surgical tactics in patients with COVID-19 and competing different acute surgical diseases (ASD). The research i…
Sponsor: Pirogov Russian National Research Medical University • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Can CT scans outsmart COVID-19? massive study aims to find out
Diagnosis CompletedThe purpose of this study is to build a large dataset of Computed Tomography (CT) images for identification of accurate CT criteria and development of deep learning-based solutions for diagnosis, quantification and prognostic estimation.
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Everyday drugs may slash COVID-19 hospitalizations, huge study hopes to prove
Prevention Recruiting nowThe rates of symptomatic COVID19 infection, hospital admission among COVID19 cases and survival would be quantified in patiens chronically treated with antihistamines or amantadine, with the aim of determining the role of antihistamines and amantadine in the evolution of COVID19.
Sponsor: Consorci Sanitari de Terrassa • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Breath-Held MRI could replace painful liver biopsies
Diagnosis Recruiting nowChronic liver disease is a major health problem worldwide. Liver fibrosis is a key feature in most chronic liver diseases. When identified early, liver fibrosis may be reversible. Currently, liver biopsy is the gold standard for the diagnosis of liver fibrosis. Liver biopsy; howe…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
5-Minute MRI could spot brain changes in rare disorder
Knowledge-focused OngoingIn this project the accuracy of a novel, rapid magnetic resonance imaging (MRI) approach to detect brain abnormalities in patients with Sturge-Weber syndrome (SWS) will be tested; this new imaging approach, that can create multiple types of MR images in about 5 minutes, without c…
Phase: NA • Sponsor: Wayne State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Gum disease repair: could a hyaluronic acid gel rival the gold standard?
Disease control CompletedThe aim of this study is to compare the effectiveness in periodontal regeneration of cross-linked hyaluronic acid at 1.8% (Hyadent BG®) with enamel matrix derivative (Emdogain®) in periodontal bone defects evaluating their clinical and radiographic variables.
Phase: PHASE4 • Sponsor: University of Valencia • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a sleep drug prevent ICU delirium in older heart patients?
Symptom relief CompletedInvestigators will evaluate the efficacy of postoperative oral suvorexant treatment on nighttime wakefulness after persistent sleep onset (WASO) among adult cardiac surgical patients recovering in the cardiac intensive care unit (ICU). The study include patients ≥ 60 years old un…
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
VA study shares genetic findings to help veterans control cholesterol
Knowledge-focused CompletedThe purpose of the Million Veteran Program- Return of Actionable Results (MVP-ROAR) Study is to develop a process to return medically actionable genetic results to living MVP participants nationwide and to determine the impact of doing so on medical management and outcomes and Ve…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New drug aims to boost immune system against advanced cancers
Disease control OngoingThe objective of study IOA-244-101 is to determine whether IOA-244 is safe and tolerable in cancer patients (Part A). In addition, the study will assess whether IOA-244 can increase the anti-tumour immune response in patients both as monotherapy and in combination pemetrexed/cisp…
Phase: PHASE1 • Sponsor: iOnctura • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New study aims to cut unnecessary pacemakers after heart valve procedure
Disease control Recruiting nowThe high incidence and variety of conduction disturbances post-TAVR represents a major challenge in the periprocedural management of TAVR recipients. Despite the growing body of knowledge on this topic, the large variability in the management of these complications has translated…
Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a simple blood injection revive aging ovaries?
Disease control OngoingConsenting women with evidence of poor ovarian reserve will be randomly assigned to treatment with either Platelet Rich Plasma (PRP) or Platelet Poor Plasma (PPP).
Phase: NA • Sponsor: Center for Human Reproduction • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a common diabetes drug help repair MS damage in kids?
Disease control Recruiting nowA randomized multiple baseline feasibility trial where participants will start taking metformin at one of 3 randomly determined points (3-months, 6-months or 9 months) during the 12-month trial. All subjects will be on a daily dose of metformin for a minimum of 3 months and a max…
Phase: PHASE1, PHASE2 • Sponsor: The Hospital for Sick Children • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New rapid test could slash antibiotic misuse in hospital pneumonia
Diagnosis CompletedHospital-Acquired Pneumonia (HAP) is the second most frequent hospital-acquired infection in the US and Europe and accounts for a large proportion of antibiotics prescribed in hospitals. Conventional methods to identify causative microorganisms (virus, bacteria) are time-consumin…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Experimental cell therapy takes on Hard-to-Treat blood cancers
Disease control CompletedThis is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) composed of autologous PBL (Peripheral Blood Lymphocytes) in patients with CLL/SLL, which has relapsed or is relapsing during treatment with ibrutinib or acalabrutinib.
Phase: PHASE1 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New HIV pill combo could simplify treatment for thousands
Disease control CompletedThis study will evaluate the safety and efficacy of a switch to Doravirine/Islatravir (DOR/ISL) (MK-8591A) (a fixed dose combination of doravirine 100 mg and islatravir 0.75 mg) in participants living with human immunodeficiency virus-1 (HIV-1) virologically suppressed on a regim…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Ulcerative colitis study aims to pinpoint the perfect treatment goal
Knowledge-focused OngoingDisease activity and response to therapy in ulcerative colitis (UC) can be assessed by a range of endpoints including symptoms, endoscopic mucosal activity, histological disease activity, and biomarkers. This study aims to determine the optimal treatment target, which is a resear…
Phase: PHASE4 • Sponsor: Alimentiv Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Could a cancer drug shrink NF2 tumors?
Disease control CompletedSubjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, f…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Elbow nerve surgery showdown: which procedure works best?
Symptom relief Recruiting nowThis research is studying two surgical procedures in a large group of people to learn about how well these procedures work as a treatment for ulnar neuropathy at the elbow (UNE). Researchers want to see which surgery is more helpful for people with ulnar neuropathy. This research…
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Jun 26, 2026 13:40 UTC
-
Laser and compression may speed leg wound recovery
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to determine the efficacy and safety of compression bandaging with fractional ablative carbon dioxide laser (FACL) compared to compression and standard dressings alone for healing of post-operative wounds of the leg. This is a randomized, SMART desig…
Phase: NA • Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC